Press Releases

Distributed: Dec 21, 2009

Alerts Login

View in Other Languages 5094 5009 4990 4969 4749 4232 

Sydney, Dec 21, 2009 (ABN Newswire) - Stirling Resources (ASX:SRE) will issue a new share entitlement issue Prospectus to raise approximately A$9.8 million to complete the recapitalisation of Monarch Gold (ASX:MON)(PINK:MARCF). The new Offer is being made as a Renounceable Entitlement issue of one new share for every share currently held, with an issue price of A$0.15 per share. It will also include one free attaching option for every new share issued, with a strike price of A$0.15. The Offer is expected to close on 22 January 2010.

Conquest Mining Limited (ASX:CQT)(PINK:CQMLF) has announced the appointment of Paul Marks, BEng(Chem), MAppFin, as a Non-Executive Director of the Company. Mr Marks' has 35 years of experience across a range of industries from foreign exchange and commodities trading, oil and gas downstream production and chemical hydrocarbon processing. Conquest's Managing Director, John Terpu, welcomed Mr Marks' appointment, saying it was part of the evolutionary process for the Company which added significant commercial and technical strengths to the Conquest board.

Mesoblast Limited (ASX:MSB)(PINK:MBLTY) announced significant preclinical trial results showing that the proprietary adult stem cell platform could be an effective treatment for diabetes.

SBI E2-Capital maintained Fufeng (HKG:0546)(PINK:FFNGY) rating at 'buy', and set its target price at 5.98 Hong Kong dollars. SBI E2-Capital estimated Fufeng will record RMB 915.3 million in 2009. Stronger-than-expected corn price and industry consolidation will be the growth momentum of Fufeng in the following several years, which MSG price surged from RMB7,719 per tonne in September 2009 to RMB10,200 in November 2009, according to the report.

Contact

Michelle Liang
Asia Business News Asia Bureau
Tel: +61-2-9247-4344
Email: michelle.liang@abnnewswire.net

  Related Companies

>>>              Conquest Mining Limited
>>>        Fufeng Group Limited
>>>        Mesoblast Limited
>>>        Monarch Gold Mining Company Limited
>>>        Stirling Resources Limited

  Related Industry Topics:

Food & Beverage | Biotech | Financial General | Health & Pharm General | Mining | 

  This Page Viewed:  (Last 7 Days: 80) (Last 30 Days: 280) (Since Published: 50090) 

50940 50090 49900 49690 47490 42320  (290430)

Events & Exhibitions

Site Search

 
 ENGLISH   All Languages

Upcoming WebCasts

Mr Mark Paton CEO
Cue Energy Resources
Tuesday, June 12, 2012

Mr Alan Hopkins CEO
Pan Asia Corporation
Tuesday, June 12, 2012

Mr Barry Dawes
Martin Place Securities
Tuesday, June 12, 2012

Dr Andrea Grant CEO
Living Cell Technologies
Monday, July 02, 2012


Conquest Mining Limited
2011.04.18  12:00 Asian Activities Report for April 18, 2011: Conquest Mining (ASX:CQT) Report Strong Production At Pajingo Gold Mine In The March Quarter
2011.02.04  13:30 Australian Market Report of February 4, 2011: iSOFT (ASX:ISF) System Significantly Reduced Hospital Medication Errors
2010.11.04  10:03 Conquest Mining Limited (ASX:CQT) Completes Acquisition Of Remaining 40% Of Pajingo Gold Mine
2010.10.18  10:15 Conquest Mining Limited (ASX:CQT) Acquires More Than 90% Of North Queensland Metals (ASX:NQM)
2010.10.13  09:57 Conquest Mining Limited (ASX:CQT) To Raise Up To A$45 Million For Future Growth
Fufeng Group Limited
2012.03.21  18:25 Fufeng Group Limited (HKG:0546) Announces 2011 Annual Results - Turnover Rose By 30.9% to Approximately RMB 8,399.2 Million
2011.08.26  12:51 Fufeng Group Limited (HKG:0546) Chairman Continues to Purchase Fufeng Shares with Confidence in Company Prospects
2011.08.22  13:42 Fufeng Group (HKG:0546) Chairman and General Manager Bought Six Million Shares in Fufeng
2011.08.16  16:07 Fufeng Group (HKG:0546) Announces 2011 Interim Results, Turnover Rose 28% to RMB 3,815.1 Million
2011.03.23  09:40 Fufeng Group (HKG:0546) Records Net Profit Of RMB966 Million For 2010, Off-Setting Rising Costs With Efficient Production
Mesoblast Limited
2012.01.31  11:09 Mesoblast Limited (ASX:MSB) FDA Clearance for Phase 2 Clinical Trial in Type 2 Diabetes
2011.11.24  11:24 Corporate Strategy Key to Mesoblast Limited (ASX:MSB) Success
2011.11.24  09:48 Mesoblast Limited (ASX:MSB) 2011 Chairman's Address and CEO's Presentation to Shareholders
2011.11.22  10:08 Positive Outcome From FDA Meeting For Type 2 Diabetes Clinical Program Using Intravenous Delivery of Mesoblast Limited (ASX:MSB) Proprietary Adult Stem Cells
2011.11.15  08:25 Mesoblast Limited (ASX:MSB) Presented Positive Results from Phase 2 Trial of Adult Stem Cell Therapy at the American Heart Association Annual Meeting
Webcast Your Annual General Meeting

Mobile Video TV

qrcode
Scan with your Mobile Phone to view ABN Newswire Video Channel on Mobile
 
City Index - A Better Way To Trade